According to the latest EU R&D Scoreboard, produced by the EU’s Joint Research Centre, R&D spending by 1,500 of the world’s largest companies grew 7.6% to €510.7 billion ($709.3 billion = €0.72 = $1) in fiscal 2011 (FY11) (results included FY12 information for some companies). In FY10, Scoreboard companies showed a 4.0% increase in R&D […]
Singapore’s gross expenditure on R&D (GERD) increased 14.8% to SGD 7.4 billion ($6.1 billion) in 2011. Spending on R&D by the private sector grew 17.2% to account for 62% of total R&D expenditures. For private R&D, spending on basic research, applied research and experimental development increased 20.1%, 11.7% and 19.7% to make up 10%, 30% […]
R&D expenditures in Hungary rose 8.5% last year to HUF 336,557 million ($1,607 million), or 1.2% of GDP. Scientific research accounted for 55% of R&D expenditures, of which basic and applied research represented 21% and 34%, respectively. Experimental development accounted for 45% of R&D spending. R&D institutes, higher education and business enterprises made up 16%, […]
In its “Autumn Statement” earlier this month, the UK government announced it will invest an additional £600 million ($967 million) in science over the next three years. The funds will support the Research Council and facilities for applied R&D. The government intends to increase the UK’s competitiveness and develop technologies in research areas such as […]
Over the coming four years, the shift to bioplastics will be spurred by Coca-Cola’s desire to produce a renewable bottle from ethylene. The long-term driver will be shale gas production. According to Morgan Stanley, in the best case scenario, the global bioplastics market could expand up to an average of 40% annually through 2020 to […]
US biotech revenues grew 4.9% last year to $53.8 billion, compared to 6.5% in 2010, according to Novel Health Strategies. By biologics class, monoclonal antibodies (mAbs) remained the largest, with sales rising 10.1% to around $20.3 billion. Ten of the 36 FDA-approved mAbs accounted for 86% of sales. The fastest growing major class was hormones, […]
The average rate of return (IRR), which is the return companies expect on investment, for 12 major pharmaceutical firms—Pfizer, Roche, Novartis, Sanofi, GlaxoSmithKline, Johnson & Johnson, AstraZeneca, Merck, Eli Lilly, Bristol-Myers Squibb, Takeda and Amgen—was 7.2% in 2012, compared with 8.4% in 2011. IRRs were determined by approximating future sales from drugs in Phase III […]
Third-quarter 2012 Life Science Index sales grew 3.4%, 4.9% excluding currency, to $3,260 million. Operating profit improved 2.8% to $658 million. Based on continuing operations, operating margin slipped 20 basis points to 20.7% of sales. Fiscal fourth-quarter revenue for Becton Dickinson’s BD Biosciences segment, which consists of Cell Analysis and Advanced Bioprocessing products, fell 6.3%, […]
Tokyo, Japan 12/3/12; Tokyo, Japan and Villach, Austria 12/7/12—Showa Denko has announced a strategic partnership with BIA Separations for joint marketing and R&D, expanding its business to include chromatography resins for biopharmaceutical manufacturing. Showa Denko currently offers lab-scale HPLC products under the Shodex brand name. Based in Austria with 80 employees, BIA Separations provides short […]
Gilbertsville, PA 12/13/12—Rockland Immunochemicals, a provider of antibodies and antibody-based tools, has acquired the TrueBlot IP (immunoprecipitation)/Western blot product line from eBiosciences, an Affymetrix company. “As eBioscience continues to focus its efforts on our evolving flow cytometry, immunoassay and immunohistochemistry applications in immunology, oncology and other therapeutic areas, we are pleased that the TrueBlot product […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
